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Abstract
Background: Nerve growth factor (NGF) is a neurotrophin crucial for the development and survival of neurons. It also acts on
cellsof the immune systemwhich express theNGF receptors TrkA and p75
NTR andcanbeproduced bythem.However, mouse
NK cells have not yet been studied in this context.
Methodology/Principal Findings: We used cell culture, flow cytometry, confocal microscopy and ELISA assays to investigate
the expression of NGF receptors by NK cells and their secretion of NGF. We show that resting NK cells express TrkA and that
the expression is different on NK cell subpopulations defined by the relative presence of CD27 and CD11b. Expression of
TrkA is dramatically increased in IL-2-activated NK cells. The p75
NTR is expressed only on a very low percentage of NK cells.
Functionally, NGF moderately inhibits NK cell degranulation, but does not influence proliferation or cytokine production. NK
cells do not produce NGF.
Conclusions/Significance: We demonstrate for the first time that mouse NK cells express the NGF receptor TrkA and that
this expression is dynamically regulated.
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Introduction
Nerve growth factor (NGF) is a neurotrophin crucial for the
development and survival of neurons [1]. It is known that this
molecule acts also on cells of the immune system and can be
produced by such cells, in particular eosinophils, monocytes/
macrophages, granulocytes, mast cells as well as B and T
lymphocytes [2,3]. NGF is an autocrine growth and survival
factor for B cells [2,3]. It can also influence proliferation of T
lymphocytes [2,3]. NGF acts through two types of receptors: (i) a
high affinity receptor which is the tyrosine kinase TrkA, specific for
NGF, and (ii) a low affinity receptor called p75
NTR, which is a
pan-neurotrophin receptor recognizing all neurotrophins of the
NGF family (NGF, brain-derived neurotrophic factor, neurotro-
phin-3 and neurotrophin-4) [1–3]. Both types of receptors have
been found on immune cells, with TrkA-transmitted signals
usually being anti-apoptotic and stimulating [1–3], whereas
p75
NTR rather transmits pro-apoptotic signals [2].
Despite intense investigations on NGF and its receptors within
the immune system, studies on NGF in the context of natural killer
(NK) cells have, to the best of our knowledge, never been
performed until very recently [4]. NK cells are lymphocytes
different from B and T cells. They are capable of killing tumor
cells and virally infected cells without prior immunization or
activation (although their functional properties are enhanced after
cytokine-mediated stimulation) and are thus part of the innate
immune response. Due to their abundant cytokine production,
they also influence adaptive immunity [5,6]. In addition, the
existence of regulatory [6] and memory [5] NK cells has been
recently demonstrated.
NK cell functions are tightly regulated by a balance between the
messages transmitted by activating receptors and those transmitted
through inhibitory receptors. Most of the latter recognize classical
or non classical major histocompatibility complex (MHC) class I
molecules on surrounding cells. In the mouse, they are represented
by NKG2A and by the Ly49 family (both are members of the C-
type lectin superfamily). When MHC class I molecules are down-
regulated or absent, which frequently occurs during tumor
transformation or viral infections, the diseased cells are selectively
killed by the NK cells whereas normal cells are spared (self
tolerance of NK cells) [6,7]. However, killing and cytokine
production can only be performed by ‘‘licensed’’ or ‘‘educated’’
NK cells characterized by the expression of at least one inhibitory
receptor for self MHC class I molecules [8,9]. NK cells without
such receptor(s) are maintained within the immune system, but
they are ‘‘unlicensed’’, which means that they are hypo-responsive
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they respond more efficiently to viruses than the ‘‘educated’’ cells,
at least in the context of cytomegalovirus infection [10].
In this paper, we investigated if NGF is produced by NK cells
and if NK cells express NGF receptors. We show for the first time
that normal mouse NK cells can express TrkA and that this
receptor is dynamically regulated on NK cells. In addition, we
performed functional NK cell studies which revealed a tendency of
NGF to negatively influence NK cell degranulation. NK cells do
not produce NGF.
Materials and Methods
Mice
C57BL/6 (B6) mice were purchased from Harlan (Horst, The
Netherlands). They were housed in a specific pathogen free animal
facility with a light/dark cycle of 12 hours and had unlimited
access to irradiated food and sterilized water. Mice were used
between 6 and 12 weeks of age. All animal experiments were
performed in accordance with the current European directives and
Luxemburgish laws. The latter do not require presenting projects
that involve animal models to an Ethics Committee.
NK cell purification, expansion and activation
Spleens were aseptically removed and single cell suspensions
were prepared after dissociation of the spleen through a cell
strainer. Red blood cells were lysed by incubation in ACK buffer
(Lonza, Basel, Switzerland) for 1 minute. This was followed by two
washes in Dulbecco’s modified Eagle’s Medium (DMEM) with
10% FCS, penicillin/streptomycin, 10 mM HEPES buffer and
50 mM 2-ME (complete medium). All cell culture ingredients were
purchased from Invitrogen (Paisley, UK). The splenocytes were
pre-purified over a nylon wool column (G. Kisker GbR, Steinfurt,
Germany) in order to remove the majority of B cells. Enriched NK
and T cells (nylon wool non adherent splenocytes, NWNA) were
then either put immediately in culture or were further purified
with the NK cell isolation kit from Miltenyi Biotec (Bergisch-
Gladbach, Germany) according to the manufacturer’s instructions.
NWNA splenocytes or purified NK cells were cultured at a
density of 2610
6 cells/ml in complete medium in cell culture
plates for various periods of time. Cultures were supplemented
with recombinant human interleukin 2 (IL-2, R & D Systems,
Abingdon, UK) at 1000 U/ml with or without recombinant
mouse NGF (R & D Systems) at 100 ng/ml. At the end of the
culture period, adherent NK cells were harvested with EDTA
(Sigma, Bornem, Belgium). Viability of the cells was assessed with
the Trypan Blue dye exclusion test.
Flow cytometry
Splenocytes or purified NK cells were first incubated for 5
minutes with anti-CD16/CD32 antibody (Ab; 1 mg/10
6 cells) and
5% goat serum for TrkA or donkey serum for p75
NTR stainings, to
reduce non specific binding. Then the TrkA (polyclonal rabbit
recognizing human, mouse and rat TrkA, Santa Cruz Biotech-
nology, Santa Cruz, CA) and p75
NTR (polyclonal goat, R & D
Systems) Ab were added for 30 minutes at 4uC. Normal rabbit IgG
and normal goat IgG were used as negative controls. After two
washing steps in FACS buffer, cells were incubated again for 30
minutes, at 4uC in the dark, in the presence of fluorochrome-
conjugated Ab directed against various surface markers, as well as
goat anti-rabbit IgG/PE and donkey anti-goat IgG/PE (both from
Jackson Immunoresearch, Soham, Cambridgeshire, UK), respec-
tively. After additional washing steps, cells were fixed with Cellfix
(BD Biosciences, Erembodegem, Belgium). Samples were analyzed
on a FACSCanto flow cytometer with FACSDiva software (BD
Biosciences) and FlowJo (Treestar, Ashland, OR).
The phenotype of the NK cells after culture with or without
NGF was analyzed by flow cytometry after direct staining of the
splenocytes with the following fluorochrome-conjugated monoclo-
nal anti-mouse Ab: Ly49C/I-FITC, Ly49D-FITC, Ly49G2-
FITC, Ly49A-PE, Ly49F-PE, NKG2D-PE (BD Biosciences),
Ly49H-FITC, CD11a-FITC, CD18-FITC, CD27-FITC, CD54-
FITC, NKG2A/C/E-FITC, CD94-PE, CD3-PECy7, NK1.1-
PECy7, CD11b-APC, DX5-APC, NK1.1-APC, CD3-Alexa Fluor
780 (eBioscience, San Diego, CA), NK1.1-Alexa Fluor 780,
CD69-PE (Biolegend, San Diego, CA).
Apoptosis assays were performed with the annexin V/
propidium iodide (PI) test. Cells were cultured with IL-2 or IL-
2+ NGF for 3 days. Then the cells were incubated in a binding
buffer (10 mM HEPES/NaOH pH 7.4, 140 mM NaCl, 2.5 mM
CaCl2) and stained with Ab against NK1.1 (FITC) and CD3
(Alexa Fluor 780) as well as with annexin V-APC for 30 minutes at
room temperature. Cells were washed and resuspended in binding
buffer. Immediately before running the samples on the flow
cytometer, PI was added.
Confocal microscopy
Cells were allowed to settle onto poly-L-lysine (Sigma) coated
coverslips for 15 minutes. Cells were then fixed with 4%
paraformaldehyde (Sigma) and incubated with 0.1 M glycin for
10 minutes. After a washing step, cells were permeabilized by
incubation with 1% BSA/PBS/saponin for 15 minutes and
labeled with the rabbit anti-mouse TrkA or goat anti-mouse
p75
NTR Ab for 30 minutes. The detection Ab used were anti-
rabbit IgG-Alexa Fluor 488 and anti-goat IgG Alexa Fluor 488,
respectively (incubation of 30 minutes in the dark). Finally cells
were washed with 1% BSA/PBS/saponin. The nuclear marker
DAPI was added for 10 minutes. Samples were mounted between
slide and coverslip in gel mounting medium (Sigma) and analyzed
on a confocal microscope LSM 510 META (Zeiss, Jena, Germany)
equipped with a 63X Plan-Apochromat oil immersion objective
(numerical aperture 1.4). Alexa-488 and DAPI were detected by
exciting samples at a wavelength of 488 nm and 405 nm
respectively, and using a 505–530 nm (for green) or a 420–
480 nm (for blue) band-pass emission filter.
Proliferation assay
Splenocytes or purified NK cells were labeled with 5(6)-
carboxyfluorescein diacetate N-succinimidyl ester (CFSE, Sigma)
at 10 mM for 15 minutes at 37uC and washed twice in complete
medium. Then labeled cells were cultured in complete medium
with IL-2 (1000 U/ml) alone or with IL-2 and recombinant mouse
NGF (rmNGF, concentrations from 0–10
4 pm) for three days.
CD107a degranulation assay
96 well plates were coated overnight with the purified anti-
NK1.1 Ab PK136 (Immunotools, Friesoyhte, Germany) at 4uC.
The day after, supernatant was removed from the plates and
NWNA splenocytes were incubated during 4 hours at 37uCi n
complete medium under the following conditions: (i) no stimula-
tion, (ii) IL-2 alone (1000 U/ml), (iii) NGF alone (100 ng/ml), (iv)
IL-2+ IL-12 (10 ng/ml) + IL-18 (20 ng/ml), and finally (v) IL-2+
IL-12+ IL-18+ NGF. A FITC-conjugated anti-CD107a Ab as well
as Golgi Plug (BD Biosciences) were present during the incubation
time. After the 4 hours, cells were stained with CD3-PECy7 and
DX5-APC Ab and analyzed by flow cytometry. The experiment
was performed similarly on NK cells activated during three days in
the presence of IL-2.
NK Cells and NGF
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NWNA splenocytes were cultured with IL-2 alone or with IL-2+
NGF during 3 days at 37uC. On day 2, cells were stimulated with
IL-2+ IL-12+ IL-18 with or without NGF overnight. The
following morning, GolgiPlug (BD Biosciences) was added to the
cells for additional 4 hours of incubation. After this period, cells
were surface-stained with CD3-PECy7 and NK1.1-APC Ab for 30
minutes at 4uC in the dark. After fixation and permeabilization
with Cytofix/Cytoperm solution (BD Biosciences) during 15
minutes, cells were stained with IFNc/PE Ab (ebioscience) for
30 minutes at 4uC in the dark, washed twice in PermWash solution
and analyzed by flow cytometry. The same experiment was also
performed with fresh NK cells kept overnight at 4uC.
NGF ELISA assay
For the determination of NGF secretion, purified splenic NK
cells were cultured in 96 well plates at a density of 2610
6 cells/ml.
After 4 days, cell-free supernatants were harvested and frozen until
use. NGF levels in the supernatant were determined by the NGF
ELISA kit from Chemicon International (Hofheim, Germany)
according to the manufacturer’s instructions. The detection limit
of NGF was 10–15 pg/ml.
Statistical analysis
Results are expressed as means 6 SEM from independent
experiments. Variance ANOVA one way Newman-Keuls test was
used for data analysis with GraphPad Prism software.
Results
NK cells express TrkA
We investigated by flow cytometry the expression of NGF
receptors on NK cells present within fresh splenocytes from B6
mice. Whereas p75
NTR could be detected only on a very low
number of NK cells (Fig. 1), TrkA was expressed by approximately
20% of the cells (Fig. 2A, Fig. 2B). The presence of TrkA in
purified spleen NK cells was further confirmed by RT-PCR (data
not shown).
When spleen NK cells were activated by culture in the presence
of IL-2, expression of TrkA increased gradually and progressively.
At day 2, half of the NK cells were TrkA+, and then the
percentage increased to nearly 100% until day 5 (Fig. 2A, Fig. 2C).
This maximal percentage did not change until day 7 (Fig. 2A).
Expression of p75
NTR was very moderately induced under these
culture conditions (Fig. 1). Confocal microscopy confirmed the
expression of TrkA by activated NK cells (Fig. 3). Despite the
staining of a fraction of resting NK cells with the anti-TrkA Ab in
flow cytometry, we could not detect TrkA-expressing fresh NK
cells by confocal microscopy (Fig. 3). This suggests that the
sensitivity of detection is higher in flow cytometry than in confocal
microscopy.
Then, we checked the expression of TrkA in fresh NK cells from
mouse bone marrow, blood and lung. In lung, it was similar to
spleen, in bone marrow, the percentage of TrkA-expressing cells
was higher (approximately 30%) than in spleen, and in blood
(approximately 15%) it was lower than in spleen (Fig. 4A). In
contrast, p75
NTR was only present on 3% of the NK cells in all the
organs tested, except in blood where it was absent (Fig. 4A).
Resting NK cells can be divided into different subsets and
maturational stages according to the relative expression of CD11b
and CD27 [6,11], the CD27-CD11b+ population being consid-
ered as the most mature. In spleen, expression of TrkA was
irregularly distributed, given that only 7.93% 61.05 SEM of the
CD27-CD11b+ NK cells were receptor-positive, while approxi-
mately 20% of the other three subsets expressed TrkA (Fig. 4B).
The same distribution, at a lower percentage of TrkA+ NK cells in
the CD27-CD11b+ population than in the other subsets, was
observed in lung and bone marrow (Fig. 4B). It therefore seems
that the percentage of TrkA+ NK cells is inversely correlated to
the maturational stage of these cells.
Thus, we show here for the first time that a substantial fraction
of fresh mouse NK cells expresses the NGF receptor TrkA, and
that this fraction increases to 100% of IL2-activated NK cells.
Figure 1. Low expression of the pan neurotrophin receptor p75
NTR on fresh and activated mouse NK cells. Splenocytes were stained
with anti-NK1.1, anti-CD3 and anti-p75
NTR Ab or isotype control as described in Materials and Methods, and analyzed by flow cytometry. Dead cells
were excluded by staining with Live Dead cell marker. A gate was set on NK cells (CD3-NK1.1+). Only a weak expression of p75
NTR (grey lines) relative
to isotype control (dashed lines) was observed at day 0 (left panel) and after 5 days of culture in the presence of IL-2 (right panel). Data shown are
from one representative experiment out of three performed.
doi:10.1371/journal.pone.0015053.g001
NK Cells and NGF
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We evaluated NK cell proliferation after staining of the cells
with the intracellular dye CFSE. NK cell division was evaluated
after culture for three days in the presence of IL-2 and varying
concentrations of NGF (from 0 to 10
4 pm). Although cell
proliferation was intense in all conditions, NGF had no influence
on the proliferation rates, whatever the concentration (Fig. 5).
Phenotype of NK cells activated in the presence of NGF
We also looked at the upregulation of the activation marker
CD69, which was similarly high (expression by more than 80% of
the NK cells after three days in culture with IL-2) in the presence
or absence of NGF (data not shown). Likewise, no differences in
the percentage of positive cells nor of the expression levels
(reflected by mean fluorescence intensities) of various NK cell
receptors (Ly49 family, NKG2A/C/E, CD94, NKG2D, adhesion
molecules CD11a, CD18 and CD54) appeared after three days of
culture with IL-2 alone or with IL-2+ NGF (Fig. 6). These results
suggest that NGF does not influence the expression of surface
molecules important for NK cell activation or inhibition.
NGF does not induce apoptosis of IL-2-activated NK cells
but does not promote survival
Apoptosis assays were performed by means of the annexin V/PI
assay on NK cells cultured for three days in the presence of IL-2
alone or of IL-2+ NGF. The percentage of cells in early apoptosis
(annexin V+PI-), in late apoptosis (annexin V+PI+) or already
dead (annexin V-PI+) was not different between the two culture
conditions (data not shown), suggesting that NGF does not induce
apoptosis but also does not promote survival when the NK cells
are activated with IL-2.
When cultured with NGF alone or with NGF + IL-2 at 100 U/
ml (1/10 of the usual dose), no cells survived in the culture (data
not shown), which could indicate that NGF is not a survival factor
for NK cells.
NGF partly inhibits NK cell degranulation but not IFNc
production
After triggering of their activating receptors, NK cells
degranulate and release the cytolytic factors perforin and
granzymes. This can be quantified through staining of CD107a,
an intracellular granule marker that appears on the cell surface
after degranulation [12,13].
At day 0, in freshly isolated NK cells, neither NGF nor IL-12+
IL-18 modulated the percentages of degranulating cells (Fig. 7A).
NGF did also not influence the numbers of IFNc-producing NK
cells at day 0 (Fig. 7B).
After three days of culture in complete medium supplemented
with IL-2 with or without NGF, NK cells were restimulated in
different ways (cf Materials and Methods for details of the
procedure). IL-12+ IL-18 increased the percentage of CD107a+
NK cells compared to the other conditions. In contrast, if NGF
Figure 2. Kinetics of the expression of the high affinity NGF receptor TrkA on mouse NK cells. Splenocytes were stained with anti-NK1.1,
anti-CD3 and anti-TrkA Ab or isotype control as described in Materials and Methods, and analyzed by flow cytometry. Dead cells were excluded by
staining with Live Dead cell marker. A gate was set on NK cells (CD3-NK1.1+), and the percentage of TrkA+ NK cells was determined. A: kinetics of
TrkA expression from day 0 to day 7 (culture in the presence of IL-2). The data shown are the means 6 SEM of three experiments. *: p,0.05: B: TrkA
expression on fresh splenic NK cells represented as contour plot. Data shown are from one representative experiment out of three performed. C: TrkA
expression on day 5 of culture with IL-2 represented as contour plot. Data shown are from one representative experiment out of three performed.
doi:10.1371/journal.pone.0015053.g002
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Materials and Methods. TrkA, but not p75
NTR, is expressed by activated NK cells (green staining). On fresh NK cells (NK Day 0), the expression level of
TrkA is probably too low to be evidenced by confocal microscopy, in contrast to flow cytometry. PC12 is a rat pheochromocytoma cell line that serves
as positive control, as it expresses both TrkA and p75
NTR at high levels. The bar corresponds to 3 mm. Data shown are from one representative
experiment out of three performed.
doi:10.1371/journal.pone.0015053.g003
Figure 4. Expression of TrkA on NK cells is different depending on the organs and the NK cell subpopulation. A: NK cells (CD3-NK1.1+)
from spleen, lung, bone marrow and peripheral blood were stained with anti-TrkA and anti-p75
NTR Ab and analyzed by flow cytometry. Dead cells
were excluded by staining with Live Dead cell marker. The percentage of TrkA+ NK cells is highest in bone marrow and lowest in blood, whereas
p75
NTR was expressed only on 3% of NK cells from spleen, lung and bone marrow. B: NK cells (CD3-NK1.1+) from the above mentioned organs were
subdivided on the basis of the relative expression of CD27 and CD11b. TrkA expression is lowest on the CD27-CD11b+ population. The data shown
are the means 6 SEM of three experiments. *: p,0.05.
doi:10.1371/journal.pone.0015053.g004
NK Cells and NGF
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at various concentrations; A: 0 pM (0 ng/ml), B: 0.1 pM (0.001 ng/ml), C: 1 pM, D: 3 pM, E: 10 pM (0.1 ng/ml), F: 10
4 pM (100 ng/ml). Then NK cells
(CD3-NK1.1+) were analysed by flow cytometry. Every peak of CFSE fluorescence corresponds to one generation of cells. Data shown are from one
representative experiment out of three performed.
doi:10.1371/journal.pone.0015053.g005
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(1000 U/ml) and NGF at different concentrations. Then NK cells (CD3-NK1.1+) were analysed by flow cytometry for the expression of the surface
markers indicated on the X-axis. Dead cells were excluded by staining with Live Dead cell marker. There were no significant differences between the
two culture conditions for any of the markers tested (p.0.05). The data represent the mean 6SEM of three different experiments.
doi:10.1371/journal.pone.0015053.g006
Figure 7. NGF reduces NK cell degranulation but does not influence IFNc production. A and B: Fresh splenocytes were assessed for
degranulation (A), reflected by the percentage of CD107a+ NK cells (CD3-NK1.1+), and for cytokine production (B), reflected by the percentage of
IFNc+ NK cells (CD3-NK1.1+). C and D: the same experiment was performed on NK cells (CD3-NK1.1+) cultured for three days in the presence of IL-2
alone (open histograms) or of IL-2+ NGF (100 ng/ml, filled histograms). The white bars correspond to cells cultured during three days with IL-2 alone,
and the grey bars correspond to cells cultured with IL-2+ NGF during the same period. On day three, cells from both culture conditions were
incubated during five hours in the different conditions shown on the X-axis. Dead cells were excluded by staining with Live Dead cell marker. NGF
inhibits degranulation to a certain extent in the condition IL-2+ IL-12+ IL-18+ NGF. The data shown are the means 6 SEM of three experiments.
doi:10.1371/journal.pone.0015053.g007
NK Cells and NGF
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This difference did however not reach statistical significance
(Fig. 7C).
When we measured IFNc production in the same experiments
(at day 3), no differences were noted between NK cells cultured in
the presence of NGF compared to its absence (Fig. 7D).
In summary of this part, it appears that NGF has a modestly
inhibiting effect on NK cell degranulation but it does not influence
IFNc production.
Activated NK cells do not produce NGF
Purified NK cells were cultured during four days in the presence
of IL-2 alone or IL-2+ lipopolysaccharide (LPS), known to induce
NGF production in monocytes/macrophages [14]. Supernatants
harvested from both NK cell culture conditions did not contain
any NGF (Fig. 8), in contrast to the positive control. This control
consisted in bronchoalveolar lavage fluid (BALF) of mice sensitized
to ovalbumin in the context of another project. It is known that
BALF of mice with an allergic inflammation of the airways
contains high levels of NGF [15]. This showed that the ELISA
assay efficiently detected NGF and that the failure to demonstrate
NGF production by NK cells was not due to a technical problem.
Discussion
In this paper, we show that around 20% of freshly isolated
mouse NK cells express the high affinity NGF receptor TrkA. This
expression is different on the various NK cell subpopulations
defined by the presence of the surface markers CD27 and CD11b,
the lowest percentage of TrkA+ NK cells being present within the
most mature subset (CD27-CD11b+). Thus, TrkA might be a
marker of relatively immature NK cells. Our observation that a
higher percentage of NK cells from bone marrow as opposed to
NK cells from spleen and blood express TrkA fits well with this
concept. It would therefore be interesting to check the expression
of TrkA on immature NK cell precursors in bone marrow. On the
other hand, TrkA is strongly upregulated during NK cell
activation, reaching 100% of the cells after 5 days of culture in
the presence of IL-2. This is not contradictory to the low
percentage of TrkA+CD27-CD11b+ NK cells, as the CD27-
CD11b+ subset is actually in replicative senescence [6,11] and
therefore unlikely to contribute to the NK cell population obtained
after culture.
Bracci-Laudiero et al. have shown that human umbilical cord
blood CD34+ cells homogeneously express relatively high levels of
TrkA and also produce NGF [16], which is the case to a much
lower extent in cord blood mononuclear cells and adult PBMC (T
cells, B cells, monocytes). These findings suggest that NGF could
have its most important effects on hematopoietic precursor cells
and/or during their differentiation towards mature cells of the
immune system. NGF could then be one of the factors driving the
development of mature peripheral NK cells from their precursors
in bone marrow.
Likewise, NGF could be predominantly produced by immature
cells, which could be the reason why we did not observe any NGF
release in cultures of IL-2-activated splenic NK cells. However,
other studies have described that activated, mature immune cells
also can produce NGF: for example monocytes/macrophages, as
already stated [14] or human CD4+ T cell clones [17]. It could be
possible that IL-2 alone and IL-2+ LPS are not the appropriate
molecules to induce NGF production by NK cells, or simply that
NK cells are unable to produce and secrete NGF.
In contrast to TrkA, the pan neurotrophin receptor p75
NTR is
not expressed by NK cells (neither resting nor activated). This is in
accordance with the recent paper by Rogers et al. showing that
resting human NK cells likewise do not express this receptor
(whereas it appears intracellularly in the case of stimulation with
IL-12) [4]. These authors also demonstrate the presence of TrkA
on approximately 45% of human peripheral blood NK cells [4].
We could not confirm the data as we found, by using another Ab
clone from the same supplier, only a very low percentage of TrkA+
human NK cells (data not shown). These discrepant results suggest
that TrkA expression by human NK cells could be a donor-
dependent phenomenon, or that they are due to the use of two
different Ab. The clone used by Rogers et al. (165126) is sold as an
Ab working in Western Blots, whereas the clone we used (165131)
is recommended for flow cytometry. A third study investigated
neurotrophin receptor expression in human PBMC and found,
with yet a different Ab from a different supplier, that
CD16+CD56+ NK cells express TrkA with a very low
fluorescence intensity [18]. However, the authors did not gate
out CD3+ T cells, so that they looked in fact at a mixture of NK
cells and NKT like T cells.
As signaling through TrkA usually stimulates the cells and
promotes survival [1–3], we performed functional assays which did
not reveal any effect of NGF on NK cell survival, proliferation and
cytokine production. In contrast, there is a tendency to a reduced
activated NK cell degranulation in the presence of NGF. The lack
of influence of NGF on most NK cell properties might come as a
surprise, as the NGF receptor TrkA is not only present on NK cells
but seems to be dynamically regulated. In accordance with our
findings, it has been described that NGF has no influence on T cell
proliferation and cytokine production [19]. On the other hand,
there are also studies showing that NGF stimulates T cell
proliferation [2,3], and the differences might be related to the
different experimental models.
In addition to its effect on degranulation, NGF might act as a
chemotactic factor for NK cells. Indeed, this neurotrophin has been
found to increase CXCL12-mediated attraction of monocytes and
macrophages [20,21] without modifying their antigen presentation
capacity and the production of proinflammatory cytokines [20].
We ruled out the possibility of a biological inactivity of the NGF
we purchased, as all the aliquots could induce neurite outgrowth in
the pheochromocytoma cell line PC12 (data not shown).
Figure 8. Activated NK cells do not produce NGF. Supernatants
from purified NK cells activated for three days with IL-2 alone or with IL-
2+ LPS are harvested and tested for NGF by ELISA. The negative control
is culture medium (DMEM +10% FCS) and the positive control is BALF
from a Balb/c mouse with allergic airway inflammation (induced by
ovalbumin). The data shown are the means 6 SEM of three
experiments.
doi:10.1371/journal.pone.0015053.g008
NK Cells and NGF
PLoS ONE | www.plosone.org 8 December 2010 | Volume 5 | Issue 12 | e15053It could be interesting to separate fresh TrkA+ from TrkA- NK
cells and to repeat all of the above mentioned experiments.
Likewise, NK cell development from bone marrow precursors
could be investigated in the presence or absence of NGF, and the
chemotaxis hypothesis could be tested. This however goes beyond
the scope of the current manuscript and will be the focus of future
research.
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